Acute and Subacute Effects of EV Iron Sucrose on Endothelial Functions in Hemodialysis Patients (original) (raw)

Iron sucrose in hemodialysis patients: Safety of replacement and maintenance regimens

Kidney International, 2004

Effect of Intravenous Iron Sucrose in Peritoneal Dialysis Patients Who Receive Erythropoiesis-Stimulating Agents for Anemia: A Randomized, Controlled Trial

José Cangiano

Clinical Journal of the American Society of Nephrology, 2006

View PDFchevron_right

A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients

jatin kothari

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2015

View PDFchevron_right

Weekly low-dose treatment with intravenous iron sucrose maintains iron status and decreases epoetin requirement in iron-replete haemodialysis patients

Isabelle Binet

Nephrology Dialysis Transplantation, 2006

View PDFchevron_right

The Effects of Intravenous Iron Treatment on Oxidant Stress and Erythrocyte Deformability in Hemodialysis Patients

Yavuz Yenicerioglu

Scandinavian Journal of Urology and Nephrology, 2003

View PDFchevron_right

Effect of intravenous iron administration frequency on AOPP and inflammatory biomarkers in chronic hemodialysis patients: A pilot study

Makoto Anraku

Clinical Biochemistry, 2008

View PDFchevron_right

Intravenous Iron Replacement Therapy Improves Cardiovascular Outcomes in Hemodialysis Patients

Claudio Orsi

in Vivo, 2021

View PDFchevron_right

Intravenous iron sucrose does not impair sonographic brachial vasodilation in peritoneal dialysis patients

Luis Montes Bolaños

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 2008

View PDFchevron_right

Iron dosing in kidney disease: inconsistency of evidence and clinical practice

Eliezer Rachmilewitz

Nephrology Dialysis Transplantation, 2014

View PDFchevron_right

Intravenous Ferric Chloride Hexahydrate Supplementation Induced Endothelial Dysfunction and Increased Cardiovascular Risk among Hemodialysis Patients

Chih-pei Lin

PLoS ONE, 2012

View PDFchevron_right

Venous versus arterial iron administration in haemodialysis. Influence on erythrocytes antioxidant parameters

Corina Muscurel

Journal of Medicine and Life, 2015

View PDFchevron_right

Very low doses of direct intravenous iron in each session as maintenance therapy in haemodialysis patients

Luis Fernández Pereira

Journal of Clinical & Experimental Nephrology, 2016

View PDFchevron_right

High-dose iron benefits in hemodialysis

Joseph S. Ladd

Pharmacy Today, 2019

View PDFchevron_right

Enhanced oxidative stress in haemodialysis patients receiving intravenous iron therapy

Paik Seong Lim

Nephrology Dialysis Transplantation, 1999

View PDFchevron_right

Safety of Iron Sucrose in Hemodialysis Patients Intolerant to Other Parenteral Iron Products

Bruce Spinowitz

Nephron Clinical Practice, 2004

View PDFchevron_right

Adrian Covic

View PDFchevron_right

KHA-CARI Guideline: Use of iron in chronic kidney disease patients

Rob MacGinley

Nephrology, 2013

View PDFchevron_right

Use of Iron Therapy in Chronic Kidney Disease

Peertechz Journals

View PDFchevron_right

Safety profiles of total dose infusion of low-molecular-weight iron dextran and high-dose iron sucrose in renal patients

Süleyman Türk

Hemodialysis International, 2011

View PDFchevron_right

Oxidative stress from rapid versus slow intravenous iron replacement in haemodialysis patients

Somchai Eiam-ong

Nephrology, 2004

View PDFchevron_right

Comparison of intravenous low molecular weight iron dextran and intravenous iron sucrose for the correction of anaemia in pre-dialysis chronic kidney disease patients: a randomized single-centre study in Nigeria

babawale bello

Clinical Kidney Journal, 2016

View PDFchevron_right

Iron supplementation in haemodialysis - practical clinical guidelines

Humberto Ventura

Nephrology Dialysis Transplantation, 1998

View PDFchevron_right

Very low doses of direct intravenous iron in each session as maintenance therapy in hemodialysis patients

Luis Fernández Pereira

Renal Failure, 2016

View PDFchevron_right

Use of intravenous iron supplementation in chronic kidney disease: an update

Peter Geisser

Iranian journal of kidney diseases, 2013

View PDFchevron_right

Evaluation of iron status in patients with end stage renal disease

Murali Alagesan

International Journal of Advances in Medicine

View PDFchevron_right

Intravenous iron therapy in renal failure: friend and foe?

David Goldsmith

Journal of Nephrology, 2004

View PDFchevron_right

Determination of iron sucrose (Venofer) or iron dextran (DexFerrum) removal by hemodialysis: an in-vitro study

Darren Grabe

2004

View PDFchevron_right

A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO)

Gert Jensen

BMC Nephrology

View PDFchevron_right

Uses and Interpretation of Iron Studies in Patients on Chronic Dialysis

Anatole Besarab, Lynda Szczech

Seminars in Dialysis, 2014

View PDFchevron_right

Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial

Bruce Spinowitz

American Journal of Kidney Diseases, 2000

View PDFchevron_right

Characterisation of hepatic and cardiac iron deposition during standard treatment of anaemia in haemodialysis

John Olynyk

Nephrology (Carlton, Vic.), 2016

View PDFchevron_right

Targets for adapting intravenous iron dose in hemodialysis: a proof of concept study

Guy Rostoker

BMC Nephrology, 2017

View PDFchevron_right

Acute and Subacute Effects of EV Iron Sucrose on Endothelial Functions in Hemodialysis Patients (original) (raw)

Related papers